Viewing nowCombinationUbid capsule
Biphenyl Dimethyl Dicarboxylate Mixture 125mg · Ursodeoxycholic Acid 50mg
Hard capsule · Prescription medication · Combination
Kips Biopharma Co., Ltd.

MFDS item code 201002044 · Notified 2010.03.12 · Insurance code 693200460
Inhibition of SGPT elevation in chronic persistent hepatitis
Chronic persistent hepatitis with continuously elevated SGPT levels is a condition where inflammation of the liver cells persists, affecting liver function. In this condition, treatment is needed to improve liver health and reduce inflammation. Medications are used to restore liver function and reduce liver cell damage. Patients can improve their liver condition with consistent management and appropriate treatment. Therefore, it is used for the treatment of chronic persistent hepatitis.
Typically, 1 capsule for adults is administered orally 3 times a day after meals.
This medication should not be used in patients with complete biliary obstruction. Additionally, this medication contains lactose and should not be administered to patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. Patients with chronic active hepatitis, liver cirrhosis, hypokalemia, severe pancreatic disease, peptic ulcers, or gallstones should exercise caution when using this medication. This medication may occasionally cause gastrointestinal symptoms such as diarrhea, nausea, and vomiting, and rarely abdominal pain, constipation, heartburn, and dyspepsia. Moreover, hypersensitivity reactions such as itching or rash may occur, and skin rashes may develop occasionally, but these symptoms typically resolve with the use of antihistamines. Transient jaundice symptoms may appear; in such cases, discontinuing the medication or using jaundice treatment agents can improve the symptoms. Rarely, generalized fatigue or dizziness may also be experienced, so caution is necessary. Post-marketing studies in South Korea have reported serious side effects, including liver cirrhosis, ascites, and acute hepatitis C, among some patients with chronic persistent hepatitis, so a connection with this medication cannot be excluded. It is important to adhere strictly to the prescribed usage and dosage. If symptoms do not improve after taking it for up to 8 weeks or if abnormal symptoms occur, immediately discontinue use and consult a doctor or pharmacist. It is important to store this medication in a safe place out of the reach of children. Women who are pregnant or may become pregnant should preferably avoid using this medication, as harmful effects on the fetus have been reported in animal studies. Lastly, this medication may enhance the effect of oral hypoglycemic agents when taken together, so it should be used with caution.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering and is ideally kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage will maintain the efficacy of the medication and prevent degradation.
A white hard capsule containing white powder
For domestic use - 30 capsules/bottle, For domestic use - 300 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationBiphenyl Dimethyl Dicarboxylate Mixture 125mg · Ursodeoxycholic Acid 50mg
Hard capsule · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationBiphenyl Dimethyl Dicarboxylate Mixture 125mg · Ursodeoxycholic Acid 50mg
Hard capsule · Prescription medication · Combination
Pharmaking Co., Ltd.
CombinationBiphenyl Dimethyl Dicarboxylate Mixture 12.5mg · Ursodeoxycholic Acid 50mg
Hard capsule · Prescription medication · Combination
(Co., Ltd.) Ilhwa
CombinationBiphenyl Dimethyl Dicarboxylate Mixture 12.5mg · Ursodeoxycholic Acid 50mg
Hard capsule · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationBiphenyl Dimethyl Dicarboxylate Mixture 125mg · Ursodeoxycholic Acid 50mg
Hard capsule · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
CombinationBiphenyl Dimethyl Dicarboxylate Mixture 125mg · Ursodeoxycholic Acid 50mg
Hard capsule · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationBiphenyl Dimethyl Dicarboxylate Mixture 12.5mg · Ursodeoxycholic Acid 50mg
Hard capsule · Prescription medication · Combination
JW Pharmaceutical Co., Ltd.
CombinationBiphenyl Dimethyl Dicarboxylate Mixture 12.5mg · Ursodeoxycholic Acid 50mg
Hard capsule · Prescription medication · Combination
Farmgen Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.